BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20167813)

  • 21. Intracranial germ cell tumors: a multi-institutional experience from three tertiary care centers in India.
    Kakkar A; Biswas A; Kalyani N; Chatterjee U; Suri V; Sharma MC; Goyal N; Sharma BS; Mallick S; Julka PK; Chinnaswamy G; Arora B; Sridhar E; Chatterjee S; Jalali R; Sarkar C
    Childs Nerv Syst; 2016 Nov; 32(11):2173-2180. PubMed ID: 27476038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country.
    Wanner M; Rohrmann S; Korol D; Shenglia N; Gigineishvili T; Gigineishvili D
    J Neurooncol; 2020 Sep; 149(2):273-282. PubMed ID: 32813185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
    Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.
    Ostrom QT; Price M; Neff C; Cioffi G; Waite KA; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2023 Oct; 25(12 Suppl 2):iv1-iv99. PubMed ID: 37793125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system tumours among adolescents and young adults (15-39 years) in Southern and Eastern Europe: Registration improvements reveal higher incidence rates compared to the US.
    Georgakis MK; Panagopoulou P; Papathoma P; Tragiannidis A; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Sfakianos G; Nikas I; Kosmidis S; Razis E; Pourtsidis A; Kantzanou M; Dessypris N; Petridou ET
    Eur J Cancer; 2017 Nov; 86():46-58. PubMed ID: 28961466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States.
    Gurney JG; Wall DA; Jukich PJ; Davis FG
    Cancer Causes Control; 1999 Apr; 10(2):101-5. PubMed ID: 10231157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
    Ostrom QT; Gittleman H; Fulop J; Liu M; Blanda R; Kromer C; Wolinsky Y; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2015 Oct; 17 Suppl 4(Suppl 4):iv1-iv62. PubMed ID: 26511214
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003.
    Arora RS; Alston RD; Eden TO; Geraci M; Birch JM
    Cancer; 2012 Sep; 118(17):4290-7. PubMed ID: 22252431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and survival of children and young people with central nervous system embryonal tumours in the North of England, 1990-2013.
    Fairley L; Picton SV; McNally RJ; Bailey S; McCabe MG; Feltbower RG
    Eur J Cancer; 2016 Jul; 61():36-43. PubMed ID: 27151553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
    Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
    J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998-2013.
    Withrow DR; Berrington de Gonzalez A; Lam CJK; Warren KE; Shiels MS
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):522-530. PubMed ID: 30464022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain, other central nervous system, and eye cancer.
    Polednak AP; Flannery JT
    Cancer; 1995 Jan; 75(1 Suppl):330-7. PubMed ID: 8001004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
    Ostrom QT; Price M; Ryan K; Edelson J; Neff C; Cioffi G; Waite KA; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2022 Sep; 24(Suppl 3):iii1-iii38. PubMed ID: 36066969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study.
    Stiller CA; Bayne AM; Chakrabarty A; Kenny T; Chumas P
    BMC Cancer; 2019 Feb; 19(1):139. PubMed ID: 30744596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.
    Surawicz TS; McCarthy BJ; Kupelian V; Jukich PJ; Bruner JM; Davis FG
    Neuro Oncol; 1999 Jan; 1(1):14-25. PubMed ID: 11554386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of OCT4 in primary central nervous system germ cell tumours.
    Ngan KW; Jung SM; Lee LY; Chuang WY; Yeh CJ; Hsieh YY
    J Clin Neurosci; 2008 Feb; 15(2):149-52. PubMed ID: 17997317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).
    Fuentes-Raspall R; Solans M; Roca-Barceló A; Vilardell L; Puigdemont M; Del Barco S; Comas R; García-Velasco A; Astudillo A; Carmona-Garcia MC; Marcos-Gragera R
    Cancer Epidemiol; 2017 Oct; 50(Pt A):1-8. PubMed ID: 28738268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do race and age vary in non-malignant central nervous system tumor incidences in the United States?
    Gittleman H; Cote DJ; Ostrom QT; Kruchko C; Smith TR; Claus EB; Barnholtz-Sloan JS
    J Neurooncol; 2017 Sep; 134(2):269-277. PubMed ID: 28667594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of second malignant neoplasms in women and girls with germ cell tumors.
    Liao Z; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
    Ann Oncol; 2017 Feb; 28(2):329-332. PubMed ID: 27864217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
    Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.